Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Mucosal Surveillance and Local Gut and Airway Defence: Study Summary

Previous related pageVitamin D, Mucosal Surveillance and Local Gut and Airway Defence: Full Evidence ReviewNext related pageVitamin D, Mucosal Surveillance and Local Gut and Airway Defence: Full Evidence Review
Study at a glance

What was studied?

This review compares ten studies of defence in the gut and airway linings. Researchers studied human cells and tissue, mice and people in trials. They measured local vitamin D activation, defence substances, microbial control and clinical infections.

What was found?

Airway cells could convert a vitamin D precursor into active hormone. Precursor means a form that requires activation. Human colon tissue, from part of the large intestine, responded to precursor, but its hormone-production rate was not directly measured. Mouse gut infection studies gave conflicting results. A small airway-liquid trial did not establish a clear difference between treatments. CORONAVIT did not clearly reduce respiratory infections with its six-month testing-and-supplement offer.

What does it mean?

A stronger gene response, altered inflammation, bacterial growth in a tissue and infection in a person are different outcomes. Local responses do not by themselves establish clinical protection.

What are the limits?

Genetically removing the receptor, the protein enabling cells to respond to hormone, is different from lowering vitamin D supply or adding active hormone directly. Related studies shared investigators or a parent trial. Some human comparisons were small. In CORONAVIT, many comparison participants also used supplements. These findings do not establish one universal improvement in defence or a personal supplement dose.

Read the full article below ↓

Cells responding to active vitamin D can change aspects of gut and airway defence. The studies measured different things: local hormone activation, cell signals, antimicrobial activity, bacteria establishing themselves in a tissue and human infections. These results cannot be treated as one universal increase in protection. Antimicrobial activity means activity against microbes. The detailed counterpart is Vitamin D, Mucosal Surveillance and Local Gut and Airway Defence: Full Evidence Review.

What was studied?

Mucosal surfaces are the linings of places such as the gut and respiratory tract. They must respond to microbes while maintaining tissue function. The review compared ten underlying studies involving human cells, human tissue, mouse models and clinical trials. Some programmes shared investigators; different publications from CORONAVIT were one parent trial.

Calcitriol is the active vitamin D hormone. The circulating precursor 25-hydroxyvitamin D3 is a form that cells can convert to active hormone. Adding active hormone directly to cells is different from taking vitamin D3 by mouth.

What did the airway studies show?

Primary human airway cells could convert precursor into active hormone and change selected defence-related responses. This was direct evidence of local activation under the tested conditions. It did not show fewer infections. A measurement of cathelicidin-related protein did not fully establish how much of it was processed into the form with antimicrobial activity. [1]

In another airway-cell experiment, calcitriol reduced some inflammatory signals after respiratory syncytial virus exposure without a detected increase in measured virus multiplication. This does not prove every antiviral function was identical or establish treatment benefit in patients. [2]

A small randomized trial tested bacterial killing by airway liquid taken from participants. Forty people supplied analysable samples. Participants were assigned by chance to vitamin D or placebo, a comparison without vitamin D. One group’s change met the paper’s statistical threshold and the other did not. This did not establish that the treatment effects differed between groups. The assay measured activity outside the body, not fewer clinical infections. [3]

These findings concern mechanisms relevant to Vitamin D and Lung Function. They do not demonstrate improved lung function or a treatment for respiratory infection.

Was local gut metabolism established in the same way?

Human colon tissue, from part of the large intestine, responded to precursor and active hormone with changes in gene activity. That showed responsiveness, but did not directly measure the rate of active-hormone production or microbial killing. It should not be described as the same conversion measurement used in the airway study. [4]

In mice, removing the receptor from gut lining cells changed stored material and measured proteins in Paneth cells, which contribute substances involved in gut defence. It also changed the microbes present. The receptor is a protein that allows cells to respond to active vitamin D. The experiment did not measure the full speed of breakdown and reuse of cell material, protection in people or benefit from supplements. [5]

Why do the mouse infection findings need qualification?

One study of mice lacking the receptor found that bacteria were initially less able to establish themselves in the gut. This depended on the microbes already present. Antibiotic alteration reversed that apparent protection. A different dietary and metabolic study found impaired defence with deficiency. Another programme found worse infection with receptor loss. [6] [7] [8]

These conflicting results cannot be settled by counting papers. Removing the receptor, lowering vitamin D supply, changing when mice were exposed during development and altering existing microbes are different experiments. The experiments do not establish one direction for every human mucosal immune response. Their relationship to Vitamin D and Innate Immunity is specific, rather than a general claim of stronger or weaker immunity.

What did human trials add?

The small trial in Crohn’s disease, a condition causing gut inflammation, studied people whose disease was relatively quiet. It did not establish between-group benefits for passage through the gut lining, blood LL-37 or disease markers. LL-37 is a substance with antimicrobial activity. A blood measurement did not directly measure release of that substance at the gut surface. The physical barrier and its immune defences are related, but remain different questions, as explained through Vitamin D and Barrier Immunity. [9]

CORONAVIT offered a blood test and supplements if vitamin D was below the study’s threshold. This policy did not clearly reduce respiratory infections over six months. Many people assigned to the comparison group also used supplements. Infections were uncommon, and information on particular groups was limited. The result does not prove that local responses are absent, but those responses cannot be presented as proven protection in people. [10]

Vitamin D responses differed between tissues, and benefit in people remains uncertain. Stronger gene activity, less inflammation, less establishment of bacteria in the gut and fewer infections remain separate outcomes.

Primary sources

[1] Hansdottir S et al. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. Journal of immunology (Baltimore, Md. : 1950). 2008;181(10):7090-7099. DOI: 10.4049/jimmunol.181.10.7090. PMID: 18981129.

[2] Hansdottir S et al. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. Journal of immunology (Baltimore, Md. : 1950). 2010;184(2):965-974. DOI: 10.4049/jimmunol.0902840. PMID: 20008294.

[3] Vargas Buonfiglio LG et al. Effect of vitamin D3 on the antimicrobial activity of human airway surface liquid: preliminary results of a randomised placebo-controlled double-blind trial. BMJ open respiratory research. 2017;4(1):e000211. DOI: 10.1136/bmjresp-2017-000211. PMID: 28883932.

[4] Mapes B et al. Ex vivo culture of primary human colonic tissue for studying transcriptional responses to 1α,25(OH)2 and 25(OH) vitamin D. Physiological genomics. 2014;46(8):302-308. DOI: 10.1152/physiolgenomics.00194.2013. PMID: 24550213.

[5] Wu S et al. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut. 2015;64(7):1082-1094. DOI: 10.1136/gutjnl-2014-307436. PMID: 25080448.

[6] Chen J et al. Dysbiosis caused by vitamin D receptor deficiency confers colonization resistance to Citrobacter rodentium through modulation of innate lymphoid cells. Mucosal immunology. 2015;8(3):618-626. DOI: 10.1038/mi.2014.94. PMID: 25315967.

[7] Lin YD et al. Vitamin D Is Required for ILC3 Derived IL-22 and Protection From Citrobacter rodentium Infection. Frontiers in immunology. 2019;10:1. DOI: 10.3389/fimmu.2019.00001. PMID: 30723466.

[8] He L et al. Vitamin D/Vitamin D Receptor Signaling Is Required for Normal Development and Function of Group 3 Innate Lymphoid Cells in the Gut. iScience. 2019;17:119-131. DOI: 10.1016/j.isci.2019.06.026. PMID: 31272068.

[9] Raftery T et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study. United European gastroenterology journal. 2015;3(3):294-302. DOI: 10.1177/2050640615572176. PMID: 26137304.

[10] Jolliffe DA et al. Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). BMJ (Clinical research ed.). 2022;378:e071230. DOI: 10.1136/bmj-2022-071230. PMID: 36215226.

Related reading

Original sources

Source

Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state

Published in Journal of immunology (Baltimore, Md. : 1950) (2010).

Publication details

[2] Hansdottir S et al. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. Journal of immunology (Baltimore, Md. : 1950). 2010;184(2):965-974. DOI: 10.4049/jimmunol.0902840. PMID: 20008294.

Read more →
Source

Effect of vitamin D3 on the antimicrobial activity of human airway surface liquid: preliminary results of a randomised placebo-controlled double-blind trial

Published in BMJ open respiratory research (2017).

Publication details

[3] Vargas Buonfiglio LG et al. Effect of vitamin D3 on the antimicrobial activity of human airway surface liquid: preliminary results of a randomised placebo-controlled double-blind trial. BMJ open respiratory research. 2017;4(1):e000211. DOI: 10.1136/bmjresp-2017-000211. PMID: 28883932.

Read more →
Source

Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn's disease: Results from a randomised double-blind placebo-controlled study

Published in United European gastroenterology journal (2015).

Publication details

[9] Raftery T et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study. United European gastroenterology journal. 2015;3(3):294-302. DOI: 10.1177/2050640615572176. PMID: 26137304.

Read more →
Source

Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)

Published in BMJ (Clinical research ed.) (2022).

Publication details

[10] Jolliffe DA et al. Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). BMJ (Clinical research ed.). 2022;378:e071230. DOI: 10.1136/bmj-2022-071230. PMID: 36215226.

Read more →